ARTES Biotechnology
EMEA
Langenfeld
,
Germany
Established
FOUNDED
2002
HEADCOUNT
2-20
FUNDING
Privately held
Keywords:
CDMO, yeast, bacteria, vaccines, enzymes, therapeutics, animal_nutrition, cosmetics, diagnostics
BUSINESS
Founded in 2002 in Langenfeld, Germany by Michael Piontek (Managing Director). Microbial CDMO specializing in development and transfer of recombinant protein production cell lines and processes. Serves pharma, animal health, enzyme manufacturers, cosmetic, diagnostic, and nutrition industries.
BIOTECH INVOLVEMENT
Core platform is the Hansenula polymorpha (Ogataea polymorpha) yeast expression system, with additional capabilities in Pichia, Saccharomyces, and E. coli. Proprietary IP includes expression elements, secretion signals, engineered host strains, and a chaperone technology for debottlenecking yeast secretion.
TECHNOLOGY PLATFORM
Hansenula polymorpha yeast platform; E. coli bacterium platform
PRIMARY PRODUCTS
CDMO services for microbial cell lines and processes; licenses for biosimilars, vaccines, enzymes; recombinant antigens, enzymes, functional proteins